Details of HTA project
Last updated: 1 July 2008 - Next update due: 8 July 2008
Research type: |
NICE Evidence Review Group Report (ERG) in support of NICE's Single Technology Appraisal process. |
Project title: |
Paclitaxel for the adjuvant treatment of early breast cancer | Project documents and links |
|
About ERG reports |
Please note: Evidence Review Group (ERG) reports do not contain Commercial in Confidence data. However there may be examples of where such data has been blacked out by the Technical Team at NICE. ERG reports are a record of what was submitted to the relevant NICE Appraisal Committee and have not been peer-reviewed beyond the team's own internal quality assurance. Further details of this appraisal can be found through the 'Project documents and links' section above. |
Project ref: |
05/54/01 |
Cost: |
This project has been commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis. |
Chief Investigator : |
Centre for Health Economics (CHE), University of York |
Start Date: |
January 2006. |
Publication date: |
This ERG report has been delivered to both the HTA programme and the NICE Appraisal Committee and is available through the link above. An article relating to this project may be published at a later date in a supplement to the HTA journal series. The expected publication date for this supplement is Early 2009. This date takes account of time needed for report editing and typesetting. |
Abstract: |
No abstract available for this project |
NRR* number, if applicable: |
(*National Research Register) |
Project Protocol: |
Project protocol not available |
URL of this page: |
http://www.hta.ac.uk/1543 |
News feeds